Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Share Option Grants

4 Jun 2010 13:10

RNS Number : 1021N
Cello Group plc
04 June 2010
 



Cello Group plc

4 June 2010

 

Cello Group plc ("Cello" or the "Company")

 

Share Option Grants

 

The Group today announces awards under its option schemes as follows:

 

Under the Cello Group plc HM Revenue and Customs Approved Share Option Plan 2009 ("Approved Plan") and under the Cello Group plc Unapproved Share Option Plan 2010 ("Unapproved Plan") options were granted on 4 June 2010 entitling certain employees and directors to acquire a total of 1,959,000 ordinary shares of 10 pence each ("Ordinary Share") at an exercise price of 31.5 pence per Ordinary Share.

 

As announced on March 16, the Board of Cello had intended not to grant any further awards under the Performance Share Plan ("PSP") and was in the process of finalising a Joint Ownership Share Plan ("JOSP"). The Board has now decided not to adopt a JOSP and instead to reinstate the PSP, renamed the Cello Group plc Performance Share Plan 2010, with new performance conditions based on Total Shareholder Return relative to a comparator group of the company's peers, as the principal long term incentive plan for its most senior employees.

 

Under the PSP, options were granted on 4 June 2010 entitling certain directors and employees to acquire a total of 1,040,000 ordinary shares of 10 pence each ("Ordinary Share") at an exercise price of 10 pence per Ordinary Share.

 

The following directors were awarded options under the Approved Plan and the PSP on 4 June 2010.

 

Mark Scott was awarded options over 72,000 shares under the Approved Plan and options over 430,000 shares under the PSP. These shares represent a total of 0.82% of the company's total issued share capital. Mark Bentley was awarded options over 72,000 shares under the Approved Plan and options over 214,000 shares under the PSP. These shares represent a total of 0.47% of the company's total issued share capital.

 

All these options will normally be exercisable from 4 June 2013 subject to continued employment and the extent to which performance conditions have been met.

 

4 June 2010

 

Enquiries:

 

Cello Group plc

 

Mark Bentley, Group Finance Director 020 7812 8463

 

Altium

 

Paul Chamberlain 020 7484 4040

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIFRIISIII
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.